Butylphthalide Injection(Hebei Saipu Ruisi Pharma)

丁苯酞注射液（河北赛谱睿思医药）

Report date: 2026/02/11 20:01:36

Base Information

Drug NameButylphthalide Injection(Hebei Saipu Ruisi Pharma)
Drug Alias Namedl-NBP丁基邻苯甲酸内酯Butilftalida丁基酞内酯NBP +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTandem pore domain potassium channels inhibitorsPlatelet aggregation inhibitors
TargetsTandem pore domain potassium channels
Therapy Area/IndicationsIschemic StrokeTrauma, Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHebei Saipu Ruisi Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHebei Saipu Ruisi Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeTrauma, Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia